Ads
related to: second line injectable antituberculosis drugs- Treatment Costs & Savings
See If You Are Eligible For Savings
Or Assistance Programs.
- Helpful Resources
Learn About An HIV Treatment
And Discover More About Dosing.
- HIV Treatment Injectable
Learn About A Treatment Option
And Find More Info Online Today.
- Get Treatment Resources
See Tools Specifically For Patients
About Dosing, Savings And More.
- Helpful Patient Tools
Find Information For Patients Here.
Visit The Official Patient Website.
- Important Safety Info
Learn About Possible Side Effects
And View Important Safety Info.
- Treatment Costs & Savings
Search results
Results From The WOW.Com Content Network
[7] [8] A drug may be classified as second-line instead of first-line for one of three possible reasons: 1) it may be less effective than the first-line drugs (e.g., p-aminosalicylic acid), 2) it may have toxic side-effects (e.g., cycloserine), or 3) it may be effective, but unavailable in many developing countries (e.g., fluoroquinolones ...
XDR-TB is defined as TB that has developed resistance to at least rifampicin and isoniazid (resistance to these first line anti-TB drugs defines multidrug-resistant tuberculosis, or MDR-TB), as well as to any member of the quinolone family and at least one of the following second-line anti-TB injectable drugs: kanamycin, capreomycin, or ...
Specifically it is a second line treatment used for active drug resistant tuberculosis. [1] It is given by injection into a vein or muscle. [1] Common side effects include kidney problems, hearing problems, poor balance, and pain at the site of injection. [1] Other side effects include paralysis resulting in the inability to breathe. [1]
For patients with RR-TB or MDR-TB, "not previously treated with second-line drugs and in whom resistance to fluoroquinolones and second-line injectable agents was excluded or is considered highly unlikely, a shorter MDR-TB regimen of 9–12 months may be used instead of the longer regimens (conditional recommendation, very low certainty in the ...
Extensively drug resistant tuberculosis is tuberculosis that is resistant to isoniazid and rifampicin, any fluoroquinolone, and any of the three second line injectable TB drugs (amikacin, capreomycin, and kanamycin). [1] TDR-TB has been identified in three countries; India, Iran, and Italy. The term was first presented in 2006, in which it ...
Specifically it is used, along with other antituberculosis medications, to treat active multidrug-resistant tuberculosis. [2] It is no longer recommended for leprosy. [3] [2] It is taken by mouth. [2] Ethionamide has a high rate of side effects. [4] Common side effects include nausea, diarrhea, abdominal pain, and loss of appetite.
Ads
related to: second line injectable antituberculosis drugs